Aurinia Pharmaceuticals Inc (AUPH)

[zzaatt]

Here you go, maybe you will understand it coming from Aurinia:

Actually this is non-responsive (LOL!).
My point was that you picked an out of context snippet with zero meaning to (I imagine) impress the impressionable with what you thought was really scary stuff.

My take on the situation is that we now have one more attempt to harass the company and suppress its value.
BUT, there was a process that already determined the validity of the patent, and they will have to present logic that was missed the first time.

Furthermore, the company went thru a long, expensive process to prove efficacy of Lupkynis, that includes ALL aspects of the drug, including dosing. The license to sell the drug includes consideration for all the effort that goes into bringing the drug to market. To allow an outfit that made no contribution to this arduous process, and to let them say, gee, it's ONLY a dosing issue, is to deny the very logic of the whose licensing process imposed by the FDA. To allow someone to muscle in AFTER Aurinia ran the regulatory gauntlet would be both unfair, and destructive of the FDA's approach to bringing drugs to the clinic. Aurinia will prevail.